Chair: Tina Vilsbøll (DNK) 14:15 – 14:19 Welcome and introductions Tina Vilsbøll (DNK) 14:19 – 14:28 First phase 3 evidence for a once-weekly insulin Athena
Chair: Filip Knop (DNK) 11:45 – 11:50 Welcome and IntroductionOverview of semaglutide, PIONEER and SUSTAIN trials Filip Knop (DNK) 11:50 – 12:00 Case based discussions
Chair: Thomas Danne (GER) 14:15 – 14:20 Welcome Thomas Danne (GER) 14:20 – 14:25 Digital health: Current Reality and Challenges(Unmet needs in glycaemic control: The
11:30 – 11:32 Introduction A. G. (Onno) Holleboom (NLD) 11:32 – 11:40 Living with NASH: a marathon, not a sprint A. G. (Onno) Holleboom (NLD)Jörn
Chair: Alice Cheng (CAN) 18:45 – 18:48 Welcome and introduction Alice Cheng (CAN) 18:48 – 19:01 Early control matters Kamlesh Khunti (UK) 19:01 – 19:14
Chair: Michael Lincoff (USA) 18:00 – 18:05 Welcome and introduction Michael Lincoff (USA) 18:05 – 18:15 CV risk: What’s weight got to do with it?
Chairs: Rachel Batterham (UK) Juris Meier (GER) Clinical challenges in obesity care: innovate, optimise and overcome 09:00 – 09:10 Welcome Rachel Batterham (UK)Juris Meier (GER)
